5.93
Evommune Inc (EVMN) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
-
|
- | - | 10.00 |
| Operating Expenses |
45.68%
34.90
|
23.95 | 29.72 | 23.33 |
| Depreciation and Amortization |
58.17%
0.552
|
0.349 | 0.326 | - |
| Operating Income/Loss |
45.68%
-34.90
|
-23.95 | -29.72 | -13.33 |
| Income Tax Expense/Benefit |
-
|
- | - | - |
| Net Income/Loss |
48.78%
-32.25
|
-21.67 | -28.27 | -12.47 |
| Basic Average Shares |
7.32%
36.14
|
33.67 | - | 1.545 |
| Diluted Average Shares |
7.32%
36.14
|
33.67 | - | 1.545 |
| Basic Earnings Per Share |
39.06%
-0.89
|
-0.64 | - | -8.07 |
| Diluted Earnings Per Share |
39.06%
-0.89
|
-0.64 | - | -8.07 |
大文字化:
|
ボリューム (24 時間):